loadpatents
name:-0.021212100982666
name:-0.017534017562866
name:-0.0016160011291504
Chaurasia; Brijnath P. Patent Filings

Chaurasia; Brijnath P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chaurasia; Brijnath P..The latest application filed is for "solid state forms of baloxavir marboxil".

Company Profile
1.15.20
  • Chaurasia; Brijnath P. - G.B. Nagar District IN
  • Chaurasia; Brijnath P. - Uttar Pradesh IN
  • CHAURASIA; Brijnath P. - Dist:Ballia IN
  • Chaurasia; Brijnath P. - Ballia IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Solid State Forms Of Baloxavir Marboxil
App 20220153753 - Muthusamy; Anantha Rajmohan ;   et al.
2022-05-19
Solid state forms of sofosbuvir
Grant 10,214,553 - Albrecht , et al. Feb
2019-02-26
Solid State Forms Of Sofosbuvir
App 20170137453 - ALBRECHT; Wolfgang ;   et al.
2017-05-18
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 8,212,071 - Kansal , et al. July 3, 2
2012-07-03
Synthesis of (S)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
Grant 8,097,754 - Kansal , et al. January 17, 2
2012-01-17
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,973,196 - Kansal , et al. July 5, 2
2011-07-05
Process for preparing intermediates of HMG-CoA reductase inhibitors
Grant 7,964,748 - Kansal , et al. June 21, 2
2011-06-21
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,960,583 - Kansal , et al. June 14, 2
2011-06-14
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,923,575 - Kansal , et al. April 12, 2
2011-04-12
Novel Asymmetric Synthesis Of (s)-(+)-3-(aminomethyl)-5-methylhexanoic Acid
App 20100324307 - KANSAL; Vinod Kumar ;   et al.
2010-12-23
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,851,651 - Kansal , et al. December 14, 2
2010-12-14
PROCESS FOR PREPARING INTERMEDIATES OF HMG-CoA REDUCTASE INHIBITORS
App 20100160663 - KANSAL; Vinod Kumar ;   et al.
2010-06-24
Novel asymmetric synthesis of (s)-(+)-3-(AMINOMETHYL)-5- methylhexanoic acid
App 20100081841 - Kansal; Vinod Kumar ;   et al.
2010-04-01
Process for preparing intermediates of HMG-CoA reductase inhibitors
Grant 7,687,660 - Kansal , et al. March 30, 2
2010-03-30
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,687,656 - Kansal , et al. March 30, 2
2010-03-30
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,586,005 - Kansal , et al. September 8, 2
2009-09-08
Process for preparing intermediates of HMG-CoA reductase inhibitors
App 20090209779 - Kansal; Vinod Kumar ;   et al.
2009-08-20
Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin
Grant 7,563,923 - Kansal , et al. July 21, 2
2009-07-21
Process for synthesis of pyrrole derivative, an intermediate for atorvastatin
App 20090081801 - Kansal; Vinod Kumar ;   et al.
2009-03-26
Process for preparing intermediates of HMG-CoA reductase inhibitors
App 20090076271 - Kansal; Vinod Kumar ;   et al.
2009-03-19
Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
App 20090069593 - Kansal; Vinod Kumar ;   et al.
2009-03-12
Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
App 20090069578 - Kansal; Vinod Kumar ;   et al.
2009-03-12
Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
App 20090069596 - Kansal; Vinod Kumar ;   et al.
2009-03-12
Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
App 20090069600 - Kansal; Vinod Kumar ;   et al.
2009-03-12
Novel asymmetric synthesis of (S)-(+)-3-(Aminomethyl)-5-methylhexanoic acid
App 20090062562 - Kansal; Vinod Kumar ;   et al.
2009-03-05
Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin
Grant 7,470,812 - Kansal , et al. December 30, 2
2008-12-30
Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-pregabalin
Grant 7,465,826 - Kansal , et al. December 16, 2
2008-12-16
Synthesis of (S)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
App 20080306292 - Kansal; Vinod Kumar ;   et al.
2008-12-11
Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
Grant 7,446,220 - Kansal , et al. November 4, 2
2008-11-04
Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin
App 20080051602 - Kansal; Vinod Kumar ;   et al.
2008-02-28
Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-pregabalin
App 20080045747 - Kansal; Vinod Kumar ;   et al.
2008-02-21
Processes for the synthesis of 3-isobutylglutaric acid
App 20070259917 - Kansal; Vinod Kumar ;   et al.
2007-11-08
Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
App 20070197827 - Kansal; Vinod Kumar ;   et al.
2007-08-23
Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin
App 20070191636 - Kansal; Vinod Kumar ;   et al.
2007-08-16
Process for the preparation of highly pure 1-[2- dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
App 20070129562 - Kansal; Vinod Kumar ;   et al.
2007-06-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed